Oncology Brothers: Practice-Changing Cancer Discussions

FDA Approval of Telisotuzumab (Teliso-V) in c-MET Overexpression - LUMINOSITY trial

Jun 27, 2025
Ask episode
Chapters
Transcript
Episode notes